Biotechnology
Sort by: Featured Most recent Most read Most commented
62 results total, viewing 21 - 30
Cumberland pharma firm moves to new office, lab in Mass.
Pharmaceutical developer Collegium Pharmaceutical Inc. has moved its operations out of Cumberland to more refined labs Canton, Mass., the company announced Thursday. more
R.I. medical tech industry building community
On Wednesday evening, Stephen Lane - chairman, chief venture officer and co-founder of Ximedica - played host to a diverse group of more than 40 members of Rhode Island's emerging med-tech community to discuss strategies to enhance connectivity and collaboration. more
Biomedical Structures announces facility expansion, new VP
Biomedical Structures LLC, a developer of biomedical textiles for medical devices, has expanded its medical textile development and manufacturing facilities and appointed a new vice president of research and development, the company announced Tuesday. more
| 1/8/13
Amgen reaches deal to use Bind’s technology to seek cancer drugs
Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences. more
Natus to acquire Grass Tech group from Astro-Med for $18.6M
San Carlos, Calif.-based Natus Medical Inc. has entered into a definitive agreement to acquire the Grass Technologies product group from technology manufacturer Astro-Med Inc. for $18.6 million, the companies announced Monday. more
| 1/7/13
Covidien’s Mallinckrodt lands FDA approval for ADHD drug
Mallinckrodt, the pharmaceuticals business of biotechnology giant Covidien PLC, has received approval from the U.S. Food and Drug Administration to manufacture and market a generic version of its Concerta tablets for the treatment of attention deficit hyperactivity disorder, the company announced Monday. more
| 12/31/12
Covidien to acquire CV Ingenuity
Medical device maker Covidien PLC has signed a definitive agreement to acquire Freemont, Calif.-based CV Ingenuity during the first quarter of 2013, the company announced Wednesday. more
| 12/26/12
Amgen $150M Aranesp misbranding plea deal approved
(Updated, 10:45 a.m.) A federal judge accepted Amgen Inc.’s plea agreement on a charge that it misbranded its anemia drug Aranesp, putting to rest a five-year probe of the company’s marketing practices. more
R.I. to receive $648K in Pfizer settlement
Rhode Island is set to receive $647,722 as part of a $42.9 million national settlement with drug maker Pfizer Inc. for the unlawful promotion of its drugs Zyvox and Lyrica. more
| 12/12/12
Amgen to acquire deCode Genetics
Amgen Inc., one of the world’s largest biotechnology companies, has agreed to buy genetic-testing company deCode Genetics Inc. for $415 million, Amgen announced Monday. more
| 12/10/12
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 Next »
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News